NANO LABS LTD-CL A (NA) Fundamental Analysis & Valuation

NASDAQ:NA • KYG6391Y1281

Current stock price

2.97 USD
+0.08 (+2.77%)
At close:
3.02 USD
+0.05 (+1.68%)
After Hours:

This NA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NA Profitability Analysis

1.1 Basic Checks

  • NA had negative earnings in the past year.
  • NA had negative earnings in 4 of the past 5 years.
  • In the past 5 years NA reported 4 times negative operating cash flow.
NA Yearly Net Income VS EBIT VS OCF VS FCFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

  • NA has a Return On Assets of -7.65%. This is in the lower half of the industry: NA underperforms 70.43% of its industry peers.
  • NA's Return On Equity of -18.17% is on the low side compared to the rest of the industry. NA is outperformed by 73.04% of its industry peers.
Industry RankSector Rank
ROA -7.65%
ROE -18.17%
ROIC N/A
ROA(3y)-27.35%
ROA(5y)-32.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NA Yearly ROA, ROE, ROICNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • NA has a worse Gross Margin (29.27%) than 69.57% of its industry peers.
  • NA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NA Yearly Profit, Operating, Gross MarginsNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

2

2. NA Health Analysis

2.1 Basic Checks

  • NA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NA has been reduced compared to 1 year ago.
  • NA has a better debt/assets ratio than last year.
NA Yearly Shares OutstandingNA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
NA Yearly Total Debt VS Total AssetsNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.66, we must say that NA is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.66, NA is doing worse than 75.65% of the companies in the same industry.
  • NA has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of NA (1.09) is worse than 88.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACCN/A
WACC9.77%
NA Yearly LT Debt VS Equity VS FCFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that NA should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.81, NA is doing worse than 79.13% of the companies in the same industry.
  • A Quick Ratio of 1.76 indicates that NA should not have too much problems paying its short term obligations.
  • NA has a Quick ratio of 1.76. This is in the lower half of the industry: NA underperforms 65.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.76
NA Yearly Current Assets VS Current LiabilitesNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. NA Growth Analysis

3.1 Past

  • The earnings per share for NA have decreased strongly by -227.04% in the last year.
  • The Revenue for NA has decreased by -47.66% in the past year. This is quite bad
  • NA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.30% yearly.
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.89%
Revenue 1Y (TTM)-47.66%
Revenue growth 3Y1.3%
Revenue growth 5YN/A
Sales Q2Q%-66.88%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NA Yearly Revenue VS EstimatesNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200M 400M 600M 800M

0

4. NA Valuation Analysis

4.1 Price/Earnings Ratio

  • NA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NA Price Earnings VS Forward Price EarningsNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NA Per share dataNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NA Dividend Analysis

5.1 Amount

  • NA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NA Fundamentals: All Metrics, Ratios and Statistics

NANO LABS LTD-CL A

NASDAQ:NA (3/23/2026, 8:08:19 PM)

After market: 3.02 +0.05 (+1.68%)

2.97

+0.08 (+2.77%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-23
Earnings (Next)08-13
Inst Owners6.72%
Inst Owner Change-62.72%
Ins Owners1.39%
Ins Owner Change0.03%
Market Cap194.02M
Revenue(TTM)41.00M
Net Income(TTM)-113.00M
AnalystsN/A
Price TargetN/A
Short Float %2.44%
Short Ratio7.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.61
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.32
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.09
BVpS1.38
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.65%
ROE -18.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.27%
FCFM N/A
ROA(3y)-27.35%
ROA(5y)-32.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.76
Altman-Z 0.66
F-ScoreN/A
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)1486.25%
Cap/Depr(5y)1011.3%
Cap/Sales(3y)76.42%
Cap/Sales(5y)59.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-47.66%
Revenue growth 3Y1.3%
Revenue growth 5YN/A
Sales Q2Q%-66.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.14%
OCF growth 3YN/A
OCF growth 5YN/A

NANO LABS LTD-CL A / NA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NANO LABS LTD-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to NA.


Can you provide the valuation status for NANO LABS LTD-CL A?

ChartMill assigns a valuation rating of 0 / 10 to NANO LABS LTD-CL A (NA). This can be considered as Overvalued.


What is the profitability of NA stock?

NANO LABS LTD-CL A (NA) has a profitability rating of 0 / 10.